What is Tiamat?
Tiamat Sciences, founded in 2019 and headquartered in Durham, North Carolina, is at the forefront of developing animal-free proteins. The company leverages a proprietary plant molecular farming platform that integrates advanced biotechnology. This innovative method allows for the sustainable and efficient production of proteins, addressing a critical need in various industries seeking alternatives to traditional animal-derived products. Tiamat's technology represents a significant advancement in the field of synthetic biology and sustainable agriculture.
How much funding has Tiamat raised?
Tiamat has raised a total of $5.4M across 1 funding round:
Angel/Seed
$5.4M
Angel/Seed (2023): $5.4M with participation from True Ventures and SeedFolio
Key Investors in Tiamat
True Ventures
True Ventures is a founder-first venture capital firm that partners with creative teams at the earliest stages, providing capital, guidance, and a strong community to help build enduring technology and artificial intelligence-driven companies.
SeedFolio
SeedFolio is a San Diego-based venture capital firm that focuses on early investments in innovative teams working on technologies aimed at combating disease and environmental challenges. The firm seeks to identify opportunities that promise significant benefits for patients and customers, while also delivering substantial profits for investors.
What's next for Tiamat?
With the recent major strategic investment, Tiamat Sciences is poised for accelerated growth and further development of its groundbreaking technology. The substantial capital infusion is expected to fuel expansion initiatives, enhance research and development capabilities, and potentially scale up production to meet increasing market demand. This strategic backing positions Tiamat to solidify its market leadership in the animal-free protein sector and explore new applications for its versatile platform, driving innovation in sustainable food and biotechnology.
See full Tiamat company page
